Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Legal
January 26, 2022 04:26 PM

Pro-ivermectin Kansas doctor-lawmaker under investigation

Associated Press
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    covid legal_i_i.png
    MH Illustration

    A Kansas doctor-lawmaker who has prescribed a parasitic worm treatment for COVID-19 symptoms acknowledged Wednesday that the state medical board has been investigating him since the summer of 2020.

    Conservative Republican state Sen. Mark Steffen disclosed the Kansas Board of Healing Arts' investigation of him during a Senate committee hearing. He was testifying in favor of a bill that would require pharmacists to fill prescriptions for both the anti-worm treatment ivermectin and the anti-malaria drug hydroxychloroquine for potentially dangerous off-label uses in treating COVID-19.

    Steffen said the medical board has been investigating him for 18 months over statements dating back to his brief time as a local county commissioner before he took his Senate seat in January 2021. He said no hearings have been scheduled.

    "They're using it to hold over me, to think they're going to silence me as I serve as a state senator," he told the committee. "And obviously, that's not working out for them."

    During the committee's two days of hearings, several Kansas doctors reported having trouble getting ivermectin prescriptions filled by pharmacists. Committee Chair Richard Hilderband, a conservative Republican from southeast Kansas, said he expects the bill to win the panel's approval after it is debated next week.

    Not a Modern Healthcare subscriber? Sign up today.

    "That is something between a doctor and a patient, on what their best way forward on care is," Hilderbrand said.

    Steffen is among the Republican-controlled Legislature's most vocal skeptics of masks and COVID-19 vaccines and critics of the U.S. government's and Democratic Gov. Laura Kelly's handling of the coronavirus pandemic. He is an anesthesiologist and pain-management specialist from Hutchinson, a city of 40,000 residents about 50 miles (80 kilometers) northwest of Wichita.

    Steffen even suggested that Kelly pushed the board to keep his case "in perpetual limbo" as a threat to him. The governor appoints the medical board's members, but Kelly said she had "nothing to do with it."

    "I can't take credit for it," she told reporters. "This is the first I've heard of it."

    While medical groups and health experts have worked to stamp out the use of ivermectin for treating COVID-19, hospitals around the nation have faced lawsuits over their refusal to give it to patients.

    Ivermectin is approved by the U.S. Food and Drug Administration to treat infections of lice, roundworms and other tiny parasites in humans. The FDA has tried to debunk claims that animal-strength versions of the drug can help fight COVID-19, warning that large doses can cause nausea, vomiting, diarrhea, seizures, delirium and even death.

    And on Wednesday, top officials at two large Kansas health systems, Ascension Via Christi and University of Kansas Health, submitted testimony opposing the bill forcing pharmacists to fill ivermectin and hydroxychloroquine prescriptions, saying it "directly conflicts" with standards for pharmacists and physicians.

    "We could not voice stronger opposition to actions such as mandating licensed professionals to act against their professional judgment and against their own licensing standards," they said.

    Susan Gile, the Kansas medical board's acting executive director, declined to respond to Steffen's comments, saying that the board does not confirm or deny ongoing investigations. She told the Kansas Senate committee that off-label uses of drugs are "not uncommon," but a doctor still has a duty to do "what a reasonable physician would have done under the same or similar circumstance."

    Steffen said the investigation does not involve complaints from patients. He said in an interview that he has prescribed ivermectin as a COVID-19 treatment, though he did not provide details.

    Asked whether he still writes such prescriptions, he said: "I'd be more than happy to do it for people."

    Steffen is not he only doctor-politician to defy the medical consensus and U.S. government guidance on COVID-19 or promote dubious medical advice. In Maryland, Republican U.S. Rep. Andy Harris, also an anesthesiologist, said on a radio program in September that he wrote an ivermectin prescription but couldn't get pharmacies to fill it.

    And U.S. Sen. Roger Marshall, another conservative Kansas Republican, said during his 2020 campaign that he took regular doses of hydroxychloroquine and last year promoted the unsupported theory that infected people have strong and long-lasting enough natural immunity to not need vaccinations.

    Nebraska's Republican state attorney general said in October  that he wouldn't prosecute doctors for ivermectin prescriptions for treating COVID-19 as long as they had patients' consent. In Kansas, state Attorney General Derek Schmidt, a Republican running for governor against Kelly this year, said he's not been asked to render an opinion and hasn't researched the issue.

    "I just haven't had a reason to look at it," he told The AP. "Generally, I think that doctors ought to control the care of their patients — I mean, that is my general approach."

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    legal columns gavel money
    How health systems are battling price-gouging allegations
    legal hospital
    FTC sues U.S. Anesthesia Partners, private equity firm
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Daily Dose Newsletter: Sign up to receive a late afternoon weekday roundup of that day’s breaking news and developments in healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing